跳至主要内容
临床试验/CTRI/2024/07/071406
CTRI/2024/07/071406尚未招募1 期

Preclinical studies to investigate citrate- functionalized Tri-Manganese Tetraoxide Nanoparticles for its Bilirubin reduction properties for risk of severe neonatal hyperbilirubinemia. - NI

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Prospective, ethical and compassionate trial for select cohort of neonates at most risk of exchange transfusion and need for escalated ? neonatal care for SNH to ascertain a long-term childhood reduction in known adverse outcomes.

排除标准

  • Infants whose parents refused to provide informed consent
  • Infants with conjugated hyperbilirubinemia
  • Infants with other threatening congenital anomalies.

研究者

相似试验